tirzepatide half life chart Alternative dosing regimens of GLP-1 receptor agonists may reduce costs and maintain weight loss efficacy Zepbound concentration levels over a
Description
In clinical trials , it produced an average weight loss of 13.6% over 64 weeks (about a year and three months)

Journal of Affective Disorders, 147 (1-3), 25-32

Dont miss this opportunity to prioritize self-care and look and feel your best

The results were presented at the American Diabetes Association (ADA) 85th Scientific Sessions 2025 and simultaneously published in The New England Journal of Medicine

Vegt et al., 2008

These side effects usually decrease over time as your body adjusts
